Description
VANDETANIB
First action · last action
2018-12-11 · 2020-03-18
Transactions
2
First transaction's obligation
$125,216
Base + all options value (sum of deltas)
$73,043
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
Yes (self-representation)
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-12-11+$125,216= $125,216
- Mod P000012020-03-18-$52,173= $73,043
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-12-11 | +$125,216 | $125,216 | VANDETANIB |
| Mod P00001· CLOSE OUT | 2020-03-18 | −$52,173 | $73,043 | VANDETANIB |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HSYJHAJULQ94)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77026P0066 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $822,505 | FY2026 |
| 36C77026P0062 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $64,656 | FY2026 |
| 36C77025P0236 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $54,060 | FY2025 |
| 36C77025P0133 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $113,280 | FY2025 |
| 36C77025P0100 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $557,700 | FY2025 |
| 36C77025P0099 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $162,394 | FY2025 |
Other recipients under 6515 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24126P0709 | SUNRISE MEDICAL (US) LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $22,142 | FY2026 |
| 36C24126P0711 | EDWARDS LIFESCIENCES LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $68,000 | FY2026 |
| 36C24126N0917 | PERMOBIL INC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $17,263 | FY2026 |
| 36C24126P0708 | VERICEL CORPORATION | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $76,400 | FY2026 |
| 36C24126P0671 | HOPELIEF SOLUTIONS LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $32,528 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24119P0210_3600_-NONE-_-NONE- · retrieved 2026-09-26.